Synthesis and characterization of pH-responsive PEG-poly (β-amino ester) block copolymer micelles as drug carriers to eliminate cancer stem cells
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
PEG-poly(β-amino ester) (PEG-PBAE), which is an effective pH-responsive copolymer, was mainly synthesized by Michael step polymerization. Thioridazine (Thz), which was reported to selectively eliminate cancer stem cells (CSCs), was loaded into PEG-PBAE micelles (PPM) prepared by self-assembly at low concentrations. The critical micelle concentrations (CMC) of PPM in water were 2.49 μg/mL. The pH-responsive PBAE segment was soluble due to protonated tertiary amine groups when the pH decreased below pH 6.8, but it was insoluble at pH 7.4. The Thz-loaded PEG-PBAE micelle (Thz/PPM) exhibited a spherical shape, and the drug loading was 15.5%. In vitro release of Thz/PPM showed that this pH-sensitivity triggered the rapid release of encapsulated Thz in a weakly acidic environment. The in vitro cytotoxicity and cellular uptake of various formulations at pH 7.4 and 5.5 were evaluated on the mammospheres (MS), which were sorted by MCF-7 human breast cancer cell lines and identified to be a CD44+/CD24− phenotype. The results of the cytotoxicity assay showed that blank micelles were nontoxic and Thz/PPM exhibited a similar anti-CSC effect on MS compared to Thz solution. Stronger fluorescence signal of Coumarin-6 (C6) was observed in MS treated by C6-loaded PPM (C6/PPM) at pH 5.5. The tumor inhibition rate and tumor weight of the free DOX and Thz/PPM groups were significantly different from those of the other groups, which free DOX and Thz/PPM effectively suppressed breast tumor growth in vivo. The above experimental results showed that Thz/PPM is an ideal and effective pH-responsive drug delivery carrier to a targeted therapy of CSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Such properties allow to employ PBAE as a core-forming segment for solubilizing poorly soluble drugs in PEG-b-PBAE polymeric micelles at physiological pH 7.4 [139].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Self-citationMis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation.
Wang, L. H., Rothberg, K. G., & Anderson, R. G. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.5.1107 · Cited by 1,177 · cited 1×
“Filipin (FLP) is a caveolae‐mediated endocytosis inhibitor [33].”
BackgroundpH-Sensitive nano-systems for drug delivery in cancer therapy
Liu, J., Huang, Y., Kumar, A., Tan, A., Jin, S., Mozhi, A., & Liang, X.-J. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.009 · Cited by 1,121 · cited 1×
“pH‐responsive drug release is one of the most important in many stimuli‐responsive controlled drug release strategies for cancer therapy [14].”
BackgroundPolymeric micelles as new drug carriers
Kwon, G. S., & Okano, T. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00401-2 · Cited by 710 · cited 1×
“Among targeted delivery systems, polymeric micelles are efficient delivery carriers for anti‐CSCs drugs [10,11].”
BackgroundPolymeric micelles drug delivery system in oncology
Gong, J., Chen, M., Zheng, Y., Wang, S., & Wang, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.012 · Cited by 570 · cited 1×
“Among targeted delivery systems, polymeric micelles are efficient delivery carriers for anti‐CSCs drugs [10,11].”
BackgroundSelf-citationUse of Statistics to Assess the Global Burden of Breast Cancer
Parkin, D. M., & Fernandez, L. M. G. (2006) · The Breast Journal · doi:10.1111/j.1075-122x.2006.00205.x · Cited by 497 · cited 1×
“Breast cancer is the leading cause of cancer deaths among the most common cancers in women worldwide [1,2].”
BackgroundPolymeric anticancer drugs with pH-controlled activation
Ulbrich, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.040 · Cited by 494 · cited 1×
“In particular, according to the physiological environment of solid tumors, more stimulus‐responsive amphiphilic block polymers have been used as carriers for delivering antineoplastic drugs into tumor tissues [13].”
BackgroundSachlos, E., Risueño, R. M., Laronde, S., Shapovalova, Z., Lee, J.-H., Russell, J., Malig, M., McNicol, J. D., Fiebig-Comyn, A., Graham, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.049 · Cited by 456 · cited 1×
“Recent studies show that Thz, which is a piperidine anti‐psychotic drug, selectively targets CSC, but is not effective for normal stem cells [6].”
BackgroundThe developing cancer stem-cell model: clinical challenges and opportunities
Vermeulen, L., de Sousa e Melo, F., Richel, D. J., & Medema, J. P. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70257-1 · Cited by 393 · cited 1×
“The only established reason behind this is the potential presence of cancer stem cells (CSCs) [3,4].”
Background
Cited by
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy
Liu, S., Khan, A. R., Yang, X., Dong, B., Ji, J., & Zhai, G. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.012 · Cited by 151
Han, X., Luo, R., Qi, S., Wang, Y., Dai, L., Nie, W., Lin, M., He, H., Ye, N., Fu, C., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01976-2 · Cited by 97
Self-citationFu, Y., Sun, J., Wang, Y., & Li, W. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02158-w · Cited by 52
“Depending on the assembly methods, polymers can spontaneously form micelles or polymersomes in water [152].”
MethodSelf-citationIqbal, S., Qu, Y., Dong, Z., Zhao, J., Khan, A. R., Rehman, S., & Zhao, Z. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.110097 · Cited by 51
Recent Progress in Bio-Responsive Drug Delivery Systems for Tumor Therapy
Cong, X., Chen, J., & Xu, R. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.916952 · Cited by 42
Zhang, H., Dong, S., Zhang, S., Li, Y., Li, J., Dai, Y., & Wang, D. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102102 · Cited by 37
Iqbal, S., & Zhao, Z. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121289 · Cited by 30
Hyaluronidase and pH Dual-Responsive Nanoparticles for Targeted Breast Cancer Stem Cells
Li, W., Zhang, X., Nan, Y., Li, J., Sun, J., Zhang, L., & Wang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.760423 · Cited by 29
Self-citationThe Interplay of Endosomal Escape and RNA Release from Polymeric Nanoparticles
Cheung, T. H., & Shoichet, M. S. (2025) · Langmuir · doi:10.1021/acs.langmuir.4c05176 · Cited by 35
Poly (beta‐amino ester) as an in vivo nanocarrier for therapeutic nucleic acids
Nezhad, M. S. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28269 · Cited by 31
Dual cancer stem cell manipulation to enhance phototherapy against tumor progression and metastasis
Shang, Q., Zhou, S., Zhou, Z., Jiang, Y., & Luan, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.10.029 · Cited by 25
Nanodrug delivery systems and cancer stem cells: From delivery carriers to treatment
Yan, J., Long, X., Liang, Y., Li, F., Yu, H., Li, Y., Li, Z., Tian, Y., He, B., & Sun, Y. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112701 · Cited by 24
Bal‐Öztürk, A., Domingo, S., Yücel, O., Erol, T., Akgüner, Z. P., Darıcı, H., Alarçın, E., & Emik, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104195 · Cited by 29
Xiong, J., Li, G., Mei, X., Ding, J., Shen, H., Zhu, D., & Wang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.826771 · Cited by 17
Oxidative Stress Amplifying Polyprodrug Micelles as Drug Carriers for Combination Anticancer Therapy
Lee, Y., Song, N., Kim, N., Yang, M., Kwon, G., Hyeon, H., Jung, E., Park, S., Kim, C., & Lee, D. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00700 · Cited by 14
Li, W., Fu, Y., Sun, J., Gong, H., Yan, R., & Wang, Y. (2024) · Discover Oncology · doi:10.1007/s12672-024-00873-w · Cited by 13
“The drug resistance of MS cells is many times stronger than that of MCF-7 cells, and strong drug resistance is an important reason for the reduction of toxicity [29].”
BackgroundSelf-citationZhou, Z.-H., Zhang, R., Jia, G.-F., Wang, Y., Luo, Y., Xu, F., & Chen, Y. (2020) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2020.10.023 · Cited by 12
Self-citationRecent advances in the application of polymeric nanoparticles to the pulmonary delivery of mRNA
Panovich, P. M., Ganesan, A., Angadi, A. R., & Piotrowski-Daspit, A. S. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2509477 · Cited by 15
Li, W., Gong, H., Fu, Y., Sun, J., & Wang, Y. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112838 · Cited by 11
Self-citationRodgers, T. M., Muzzio, N., Watson, C. D., & Romero, G. (2021) · Bioengineering · doi:10.3390/bioengineering8020016 · Cited by 9
Adaptive Polymers: The pH-Responsive Revolution in Biomedical Materials
Musale, S., Jarande, S. S., Nikam, A., Pawar, R., Kodange, N. N., Kapare, H. S., Nison, M., Pai, V., Aher, A. A., Datta, D., et al. (2026) · ACS Omega · doi:10.1021/acsomega.6c01425 · Cited by 7
Li, W., Gong, H., Yan, S., Fu, Y., Huang, J., Mei, Y., & Wang, Y. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c11872 · Cited by 5
Self-citationBlock copolymer micelles as long-circulating drug delivery vehicles
Abuwatfa, W. H., AlSawaftah, N., & Husseini, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00023-9 · Cited by 5
Kharaziha, M., Salehi, S., & Scheibel, T. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400329 · Cited by 4
Properties of Polymers Enabling In Situ Gel Formation
Bhowmik, A., Dey, C., Giri, T. K., & Mukherjee, K. (2026) · Springer eBooks · doi:10.1007/978-981-95-6619-8_2 · Cited by 1
Kaplan, Ö., TUNCEL, N., Bal, K., Çelik, S. K., & Gök, M. K. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108438 · Cited by 1
Applications of Block Copolymers as Stimuli-Responsive Copolymers
Dutta, G., Guha, N., Dastidar, D. G., & Das, A. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-6917-3_16 · Cited by 1
Use of Nanocellulose Hydrogels for Ophthalmic Applications
Dutta, G., Dastidar, D. G., & Sugumaran, A. (2024) · doi:10.1002/9781394172825.ch12 · Cited by 1
Aptamer-functionalized micelles for targeted cancer therapy
Salahpour‐Anarjan, F., Zare, F., Hosseini, F., Ahranjani, S. D., Alipour, M., & Gozali, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85881-6.00015-4
Nanomedicine strategies for acute respiratory distress syndrome management
Yu, Y., Qiu, L., & Tayari, K. (2025) · Bioinspired Biomimetic and Nanobiomaterials · doi:10.1680/jbibn.24.00050 · Cited by 1
Metadata
- Authors
- Li, W., Sun, J., Zhang, X., Jia, L., Qiao, M., Zhao, X., Hu, H., Chen, D., & Wang, Y.
- Affiliations
- Shenyang Pharmaceutical University (CN)
- Northeast Forestry University (CN)
- Heilongjiang University of Chinese Medicine (CN)
- Department of Pharmacy, Heze Medical College, Heze 274000, China
- Corresponding author
- Chen, Dawei
- Wang, Yanhong
- ORCID
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-01-30
- Volume
- 12
- Issue
- 2
- Pages
- 111
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC7076537
- OpenAlex
- W3003482337
- Cited by
- 31
- References
- 36
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 5 · 2020: 4
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- pH-responsive micelles, cancer stem cells, thioridazine, drug carriers, critical micelle concentration, pH-responsive drug release, mammospheres, breast cancer, CD44+/CD24- phenotype, doxorubicin, coumarin 6, tumor growth inhibition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.